DigestRedComo funciona
Red
/
Empresas
Pr
No verificado

Pretzel Therapeutics

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

5 Comunicados de prensa

Ver todos los comunicados de prensa
11/03/2026
Eventos
Industria
Ciencia
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Pretzel Therapeutics Presents Preclinical Data on PX578 at MDA 2026, Further Supporting Clinical Advancement in Individuals Living with POLG Disease
Fuente
Pretzel Therapeutics
Editor
Business Wire
1.00
0
04/11/2025
Ciencia
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Eventos
Industria
Pretzel Therapeutics Presents Preclinical Data Supporting POLRMT as a Novel Target for the Treatment of Metabolic Disease at ObesityWeek 2025
Fuente
Pretzel Therapeutics
Editor
Business Wire
1.00
0
03/09/2025
Pretzel Therapeutics Strengthens Leadership with Appointment of Ashish Dugar, Ph.D., MBA as Chief Development Officer
Fuente
Pretzel Therapeutics
Editor
Business Wire
1.00
0
09/04/2025
Industria
Ciencia
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Pretzel Therapeutics Announces Publication in Nature Unveiling Discovery of Novel Small Molecule Activators for the Treatment of POLG Disorders and Other Conditions Related to mtDNA Depletion
Fuente
Pretzel Therapeutics
Editor
Business Wire
1.00
0
03/04/2025
Industria
Ciencia
Biotecnología
Medicina - Varios
Salud
Farmacéutica
Sanidad
Pretzel Therapeutics Initiates Phase 1 Clinical Study Evaluating PX578, Lead Therapeutic in its Bioenergetics Restoration Franchise
Fuente
Pretzel Therapeutics
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0